Morgan Stanley gave Chemours an equal weight rating, while Royal Bank of Canada upped its price target, with MarketBeat providing the average rating.
2 reports, 2 independent
Updated Aug 16
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley gave Chemours an equal weight rating, while Royal Bank of Canada upped its price target, with MarketBeat providing the average rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Chemours
American chemical company
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
-
Royal Bank of Canada
financial institution in Canada
Related events
- MarketBeat reports average rating and target price for SS&C Technologies, while RBC boosts targets and Jefferies reduces its price objective.
- Morgan Stanley reissued an overweight rating for Wynn Resorts, which was reported by MarketBeat.
- Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.
- Financial firms (RBC, Citigroup, Morgan Stanley) issued rating and price target updates for 10X Genomics.
- Morgan Stanley released target price analysis and Scotiabank published rating reports regarding Southern Copper Corporation on September 11, 2026.